ArticleSmall (Weinheim an der Bergstrasse, Germany)2025
Continuous Flow Synthesis of Copper Oxide Nanoparticles Enabling Rapid Screening of Synthesis-Structure-Property Relationships.
Article in Small (Weinheim an der Bergstrasse, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Synthesis of Crystalline Copper Oxide (CuO) Nanoparticles via a Combined Polyol and Thermal Decomposition in Air.Materials (Basel, Switzerland) · 2026Article
- Recent Developments in Automated Reactors for Plasmonic Nanoparticles.Nanomaterials (Basel, Switzerland) · 2025Review
- The Influence of Pore Size on the Photocatalytic and SERS Performance of Nanoporous Au-Ag Shells.Molecules (Basel, Switzerland) · 2025Article
- Continuous Flow Synthesis of Copper Oxide Nanoparticles Enabling Rapid Screening of Synthesis-Structure-Property Relationships.Small (Weinheim an der Bergstrasse, Germany) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
An adjustable and scalable method for the continuous flow synthesis of cupric oxide nanoparticles (CuO NPs), targetted the reduction of their activity to synthetic biomembranes to inform the fabrication of nanoparticles (NPs) with reduced toxicity for commercial applications. By manipulating key factors; temperature, residence time, and the ratio of precursor to reductant, precise control over the morphology of CuO NPs is achieved with X-ray diffraction (XRD) and transmission electron microscopy (TEM) confirming the formation of needle-shaped CuO NPs. One-variable-at-a-time studies reveal a relationship between the synthesis conditions and the characteristics of the resultant NPs, with CuO NPs varying controllably between 10-50 nanometres in length and 4-10 nanometres in width. Subsequently, Design of Experiment (DoE) exploration of the biomembrane activity of the CuO NPs intriguingly revealed only minimal effects on their membrane-disruptive properties in the chemical space defined by the synthesis conditions explored. This study marks a significant milestone, as it introduces a facile, easy to scale, continuous flow synthesis of CuO NPs, with control over the length and width of the needle NPs and reveals that, regardless of the exact shape, the NPs have minimal impact on biomembranes, prompting more detailed exploration in the future for use in biomedical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.